One company in particular was flagged for reporting a high number of at-home assessments for a small group of conditions, which the report called, “unusual.”

A new investigation by the Department of Health and Human services (HHS) has ended with a recommendation for tighter oversight of some Medicare Advantage (MA) plans—which HHS said have submitted claims resulting in $9.2 billion in overpayments, using 2016 data.

The investigation by the HHS’ Office of the Inspector General (OIG) focused on MA plans, which are private plans used by 40% of Medicare beneficiaries (25 million enrollees) in the U.S. The study looked at risk-adjusted payments, which is a way that HHS provides additional payments for patients who may have more expensive conditions.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.